Unichem Laboratories has registered 56.53% jump in its net profit at Rs 23.23 crore for the fourth quarter ended March 31, 2012. The company had posted a net profit of Rs 14.84 crore for the same in fiscal 2010-11.
The pharmaceutical company’s total income stood at Rs 192.97 crore for the quarter ended March 31, 2012 as against Rs 178.10 crore in the year-ago period, up by 8.35%.
However, net profits of the Mumbai-based firm declined by 23.99% to Rs 82.46 crore for the financial year ended March 31, 2012 from Rs 108.49 crore in the year-ago period.
Total income of the company stood at Rs 803.18 crore for the year ended March 31, 2012 as against Rs 764.73 crore in the previous fiscal, rose 5.01%.
Apart from its formulations business, Unichem also manufactures active pharmaceutical ingredients.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: